Insights

Strategic financing ExpressCells has demonstrated early-stage funding activity with equity financing rounds totaling around $1.8M, indicating readiness for additional partnerships or co-development deals that align with gene editing and biotechnology research tools.

Spun out expertise As a Temple University spin-out focused on gene editing, ExpressCells can be positioned as a partner for access to specialized academic collaborations, early-access tools, or grant-supported projects that leverage university-affiliated IP and talent.

Small team agility With a compact team size (2-10 employees), there is an opportunity to offer scalable outsourcing arrangements, pilot programs, or white-label services that help accelerate product development without necessitating large internal headcounts.

Commercial readiness Recent financing activity and leadership appointments suggest active governance and growth potential; sales conversations can target institutional buyers and research labs seeking dependable suppliers for gene editing reagents, software, or data analytics tools.

Competitive positioning Compared to large CROs and biotech suppliers, ExpressCells presents an opportunity to package highly specialized, agile offerings at a niche price point, appealing to academic and early-stage biotech customers who value speed and personalized service.

Similar companies to ExpressCells

ExpressCells Tech Stack

ExpressCells uses 8 technology products and services including Google Ads, LinkedIn Ads, WordPress, and more. Explore ExpressCells's tech stack below.

ExpressCells's Email Address Formats

ExpressCells uses at least 1 email format:
ExpressCells Email FormatsExamplePercentage
FLast@xpresscells.comJDoe@xpresscells.com
100%

Frequently Asked Questions

What is ExpressCells's official website and social media links?

Minus sign iconPlus sign icon
ExpressCells's official website is xpresscells.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does ExpressCells generate?

Minus sign iconPlus sign icon
As of July 2026, ExpressCells's annual revenue is estimated to be <$1M.

What is ExpressCells's SIC code and NAICS code?

Minus sign iconPlus sign icon
ExpressCells's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ExpressCells have currently?

Minus sign iconPlus sign icon
As of July 2026, ExpressCells has approximately 4 employees across 1 continents, including North America. Key team members include Chief Executive Officer: M. H. Explore ExpressCells's employee directory with LeadIQ.

What industry does ExpressCells belong to?

Minus sign iconPlus sign icon
ExpressCells operates in the Biotechnology Research industry.

What technology does ExpressCells use?

Minus sign iconPlus sign icon
ExpressCells's tech stack includes Google Ads, LinkedIn Ads, WordPress, Google Workspace, Google Sheets, Piwik, Cloudflare Rocket Loader and Gravity Forms.

What is ExpressCells's email format?

Minus sign iconPlus sign icon
ExpressCells's email format typically follows the pattern of FLast@xpresscells.com. Find more ExpressCells email formats with LeadIQ.

How much funding has ExpressCells raised to date?

Minus sign iconPlus sign icon
As of July 2026, ExpressCells has raised $1.8M in funding. The last funding round occurred on Oct 23, 2020 for $591K.

When was ExpressCells founded?

Minus sign iconPlus sign icon
ExpressCells was founded in 2018.
ExpressCells logo

ExpressCells

Biotechnology ResearchPennsylvania, United States2-10 Employees

ExpressCells is a biotechnology research company based in Philadelphia, Pennsylvania. It has been described as a gene editing technology company that originated as a spin-out from Temple University, supported by a small team. The available information notes that the firm is no longer active.

One notable milestone in its history was the appointment of a new member to its Board of Directors in 2019. The provided materials do not detail its products, services, or customer base, focusing instead on its place within the biotechnology research landscape.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
2-10

Section iconFunding & Financials

  • $1.8M

    ExpressCells has raised a total of $1.8M of funding over 2 rounds. Their latest funding round was raised on Oct 23, 2020 in the amount of $591K as a Venture Round.

  • <$1M

    ExpressCells's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.